Detail akcie TEVA PHARMACEUT.INDUSTR.SP-ADR online

Business Summary: Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Teva Pharmaceutical Industries Ltd (ADR) revenues increased 6% to $15.85B. Net loss decreased 77% to $559M. Revenues reflect North America segment increase of 9% to $8.12B, Europe segment increase of 7% to $4.84B, International Markets segment increase of 3% to $1.96B. Lower net loss reflects North America segment income increase of 20% to $2.4B.